Option Care Health, Inc. (NASDAQ:OPCH) Holdings Lowered by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale cut its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 27.2% in the 2nd quarter, HoldingsChannel reports. The fund owned 6,380 shares of the company’s stock after selling 2,387 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Option Care Health were worth $178,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Westfield Capital Management Co. LP boosted its stake in Option Care Health by 19.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 4,482,732 shares of the company’s stock valued at $151,023,000 after purchasing an additional 735,344 shares in the last quarter. Schroder Investment Management Group lifted its holdings in Option Care Health by 7.3% in the 4th quarter. Schroder Investment Management Group now owns 1,417,591 shares of the company’s stock valued at $47,759,000 after acquiring an additional 96,587 shares during the last quarter. Congress Asset Management Co. MA lifted its stake in Option Care Health by 37.2% during the fourth quarter. Congress Asset Management Co. MA now owns 203,569 shares of the company’s stock valued at $6,858,000 after purchasing an additional 55,233 shares during the last quarter. Harbor Capital Advisors Inc. boosted its holdings in Option Care Health by 317.9% during the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after buying an additional 73,312 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky grew its position in Option Care Health by 40.9% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 394,254 shares of the company’s stock worth $13,282,000 after buying an additional 114,509 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Performance

Shares of OPCH stock opened at $31.90 on Friday. The company has a market capitalization of $5.54 billion, a price-to-earnings ratio of 20.99, a P/E/G ratio of 2.46 and a beta of 1.29. Option Care Health, Inc. has a 1-year low of $26.11 and a 1-year high of $34.63. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. The stock’s fifty day simple moving average is $31.20 and its 200-day simple moving average is $30.47.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.03. The company had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The business’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.63 EPS. On average, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several analyst reports. Barrington Research upped their target price on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. JMP Securities began coverage on shares of Option Care Health in a report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 target price for the company.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.